Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments

Background: Advances in cancer medicines have resulted in tangible health impacts, but the magnitude of benefits of approved cancer medicines could vary greatly. Health Technology Assessment (HTA) is a multidisciplinary process used to inform resource allocation through a systematic value assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Trapani, Dario, Tay-Teo, Kiu, Tesch, Megan E., Roitberg, Felipe, Sengar, Manju, Altuna, Sara C., Hassett, Michael J., Genazzani, Armando A., Kesselheim, Aaron S., Curigliano, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406873/
https://www.ncbi.nlm.nih.gov/pubmed/36005193
http://dx.doi.org/10.3390/curroncol29080455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406873/
https://www.ncbi.nlm.nih.gov/pubmed/36005193
http://dx.doi.org/10.3390/curroncol29080455

Ejemplares similares